Evidence map›Paper›PMID 37375767›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Chaperone Activity and Protective Effect against Aβ-Induced Cytotoxicity of

David Sanchez-Rodriguez, Idsa Gonzalez-Figueroa, Merlis P Alvarez-Berríos

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David Sanchez-RodriguezDepartment of Science and Technology, Inter American University of Puerto Rico at Ponce, Ponce, PR 00715-1602, USA.
Idsa Gonzalez-FigueroaDepartment of Science and Technology, Inter American University of Puerto Rico at Ponce, Ponce, PR 00715-1602, USA.
Merlis P Alvarez-BerríosDepartment of Science and Technology, Inter American University of Puerto Rico at Ponce, Ponce, PR 00715-1602, USA.ORCID 0000-0001-7543-1129
InterAmerican University of Puerto Rico · PR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common type of dementia and is listed as the sixth-leading cause of death in the United States. Recent findings have linked AD to the aggregation of amyloid beta peptides (Aβ), a proteolytic fragment of 39-43 amino acid residues derived from the amyloid precursor protein. AD has no cure; thus, new therapies to stop the progression of this deadly disease are constantly being searched for. In recent years, chaperone-based medications from medicinal plants have gained significant interest as an anti-AD therapy. Chaperones are responsible for maintaining the three-dimensional shape of proteins and play an important role against neurotoxicity induced by the aggregation of misfolded proteins. Therefore, we hypothesized that proteins extracted from the seeds of

Indexed as

Alzheimer’s diseasechaperonesfibril inhibitionprotective effectprotein extract

Identifiers

PMID37375767
PMCPMC10301216
OpenAlexW4378908356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.